多発性硬化症



All Public Reviews


The Multiple Sclerosis Outcomes Assessments Consortium (the Critical Path Institute and the National MS Society) use CDISC standards to standardize and analyze MS data to qualify a new measure of disability as a primary or secondary endpoint for future trials of MS therapies